SlideShare a Scribd company logo
FGR
outlines
• Introduction
• Etiology Fetal growth restriction
• Classification
• diagnosis
• management
• Complication
• delivery timing
• fetal surveillance
Introduction
• FGR is suspected when the sonographically estimated fetal weight is below the tenth
percentile
• Next to prematurity, intrauterine fetal growth restriction (FGR) is the second leading cause of
perinatal mortality
• Compared with appropriately grown counterparts, perinatal mortality rates in growth-
restricted neonates are 6 to 10 times greater. Perinatal mortality rates as high as 120 per 1000
for all cases of FGR and 80 per 1000 after exclusion of anomalous infants have been reported.
As many as 53% of preterm stillbirths and 26% of term stillbirths have FGR
• In survivors, the incidence of intrapartum asphyxia may be as high as 50%.
• Intrauterine growth restriction, fetal growth restriction (FGR), and small for gestational age (SGA)
are terms frequently used interchangeably when describing the small fetus; in this chapter we
use FGR.
REGULATION OF FETAL GROWTH
• Fetal growth is regulated at multiple levels and requires successful development of the placental
interface between maternal and fetal compartments.
• Fetal growth may be divided into three phases. Te initial phase
• o hyperplasia occurs in the rst 16 weeks and is characterized
 
• by a rapid rise in cell number. Te second phase, which extends
• up to 32 weeks’ gestation, includes both cellular hyperplasia
• and hypertrophy. A ter 32 weeks, etal mass accrues by cellular hypertrophy,
 
• it is during this phase that most etal at and glycogen accumulate. Te corresponding etal-
  
growth rates during these three phases approximate 5 g/d at 15 weeks’ gestation,15 g/d at 24
weeks’, and 30 g/d at 34 weeks
• Eighty percent of fetal fat gain is accrued after 28 weeks’ gestation, providing essential
body stores in preparation for extrauterine life. From 32 weeks onward, fat stores increase
from 3.2% of fetal body weight to 16%, which accounts for the significant reduction in body
water content.3 Several possibl
Fetal growth restrictionor intrauterine GR
By 16 weeks’ gestation, the maternal microvillous and fetal basal layers in the placenta are only 4 μm apart, posing little
resistance to passive diffusion. Elaboration of active transport mechanisms for three major nutrient classes—glucose,
amino acids, and free fatty acids
Later increase in villous surface and increase placental vasculature
Extravillous cytotrophoblast invasion of the maternal spiral arteries results in progressive loss of the musculoelastic
media, a process paralleled on the fetal side by continuous villous vascular branching. This results in significant
reduction of blood flow resistance in the uterine and umbilical vessels, which converts both circulations into low-
resistance, high-capacitance vascular bed
Owing to these developments, as much as 600 mL/min of maternal cardiac output reaches a placental exchange area of
up to 12 m2 at term. In the fetal compartment, this is matched with a blood flow volume of 200 to 300 mL/kg per minute
throughout gestation. This magnitude of maternal blood flow is necessary to ensure maintenance of placental function
that is energy intensive and consumes as much as 40% of the oxygen and 70% of the glucose supplied. Optimal fetal
growth and development depends on a magnitude of maternal nutrient and oxygen delivery to the uterus that leaves
sufficient surplus for fetal substrate utilization
Of the actively transported primary nutrients, glucose is the predominant oxidative fuel, whereas amino acids
are major contributors to protein synthesis and muscle bulk. Glucose and, to a lesser extent, amino acids drive the
insulin-like growth factors axis and therefore stimulate longitudinal fetal growth.
Near term, 18% to 25% of umbilical venous flow shunts through the DV to reach the right atrium in this high-
velocity stream; 55% reaches the dominant left hepatic lobe, and 20% reaches the right liver lobe
DEFINITION AND PATTERNS OF FETAL GROWTH RESTRICTION
• classification
• Based on absolute birthweight(old)
 low birthweight (LBW; <2500 g),
 very low birthweight (VLBW; <1500 g),
 extremely low birthweight (ELBW; <1000 g), or
 macrosomia (>4000 g)
Based birthweight percentile (current)
 very small for gestational age (VSGA; <3rd percentile),
 small for gestational age (SGA; <10th percentile),
 average for gestational age (AGA; 10th to 90th percentile), or
 large for gestational age (LGA; >90th percentile).
Draw back
normal birthweight percentile, but abnormal body proportion as a result of differential growth delay may
be missed
Can’t d/t between the small neonate normally grown given his or her genetic potential and the neonate
that is growth restricted because of a disease process.
The ponderal index ([birthweight in grams/crown heel length]3 × 100) has a high accuracy for the
identification of SGA and macrosomia.
The ponderal index correlates more closely with perinatal morbidity and mortality than traditional
birthweight percentiles, but it may miss the proportionally small and lean growth-restricted neonate
Based on body proportion
 the asymmetric growth pattern,
somatic growth (e.g., the abdominal circumference [AC] and lower body) shows significant delay, whereas there is
relative or absolute sparing of head growth.
Two process , First, liver volume is reduced because of lack of deposition and depletion of
glycogen stores as the result of limited nutrient supply, which leads to a decrease in AC.
Second, elevations in placental blood flow resistance increase right cardiac afterload and
promote diversion of the cardiac output toward the left ventricle because of the parallel
arrangement of the fetal circulation and the presence of central shunt, This increases blood
and nutrient supply to vital structures in the upper part of the body, presumably resulting in
relative “head sparing
 the symmetric growth pattern, body and head growth are similarly affected.
• The pattern of fetal growth depends on the underlying cause of growth delay and on
the timing and duration of the insult.
 Uteroplacental insufficiency is typically associated with asymmetric fetal growth delay.
 Aneuploidy, nonaneuploid (genetic) syndromes, and viral infections either disrupt the
regulation of
growth processes or interfere with growth at the stage of cell hyperplasia
→→symmetric GR
Fetal growth restrictionor intrauterine GR
ETIOLOGIES OF INTRAUTERINE GROWTH RESTRICTIO
 Fetal causes
• Teratogenic exposure
• Fetal infection 10%
≤≤
• Genetic disorders
• Structural abnormalities
Chromosomal abnormalities may be
detected
o 17% of FGR % ,,,,,, some says less
than 1o%
o 66% of u/s confirmed fetal
malformation
o 53 % of trisomy 13 and 64% trisomy 18
Maternal cause
• Hypertensive disease
• Pregestational diabetes
• Cyanotic cardiac disease
• Autoimmune disease
• Restrictive pulmonary disease
• High altitude (>10,000 feet)
• Tobacco/substance abuse
• High altitude (>10,000 feet)
• Tobacco/substance abuse
• Malabsorptive ds/malnutrition
• Multiple gestation
• Thrombophilias
• Drugs eg phenytoin
Placental causes
• Primary placental disease
• Placental abruption and infarction
• Placenta previa
• Placental mosaicism
MANIFESTATIONS OF FETAL GROWTH RESTRICTION
Maternal Impacts
o Due to poor placentation ,
 suboptimal maternal volume expansion,
 increased vascular reactivity, and
 “flat” curve on the glucose tolerance test
 Lack of spiral and radial A physiologic transformation into low-resistance vessels (expected at
22-24wks)
Maternal placental floor infarcts,
fetal villous obliteration, and
 fibrosis
• Fetal Impacts
Metabolic manifestations
Initially after oxygen and nutrient deficit ,fetal supply is compromised first, whereas placental
nutrition is preferentially maintained. Both affected later on
If uterine oxygen delivery falls below a critical value (0.6 mmol/kg/ min ),
 Fetal hypoxemia or hypoxia
 Hypoglycemia
 mild hypoglycemia blunted pancreatic insulin gluconeogenesis(from liver
glycogen)
worsened nutrition abn worsened hypoglycemia
 later on amino acids and fatty acids may procure gluconeogenesis after liver glycogen fail
Fetal growth restrictionor intrauterine GR
Fetal endocrine manifestations
 Low glucose and amino acid low insulin and ILGF –I &II Impaired fetal GT and
dec fetal linear growth
 Leptin-coordinated deposition of fat stores is similarly affected.
 Significant elevations of corticotropin-releasing hormone, adrenocorticotropic hormone, and
cortisol and a decline in active vitamin D and osteocalcin are proportional to the severity of
placental dysfunctio
 These hormonal imbalances are believed to have additional negative impacts on linear and
growth, bone mineralization, and the potential for postpartum catch-up growth.
 Thyroid gland dysfunction may develop hypotyroidism as indicated by low levels of T3&T4
despite elevated TSH level
 Elevations in serum glucagon, adrenaline, and noradrenaline …RF for adulthood DM
• Fetal hematologic response
 Polycythemia (erythropoietin release and stimulation of red blood cell (RBC) production )
 Inc Oxygen carrying and the buffering capacity
 elevated NRBC counts correlate with metabolic and cardiovascular status and are
independent markers for poor perinatal outcome
 fetal anemia and thrombocytopenia (due to placental consumption)
 Fetal immune manifestation
 the cellular and humoral dysfunction (WBC,IG,B-cells,t-lymphocyte…)
• Fetal cardiovascular responses
Early -adaptive in nature and result in preferential nutrient streaming to essential organs
-dec umbilical venous flow volume ---earliest feature
-Elevation of blood flow resistance in the pulmonary vascular bed and subdiaphragmatic
circulation
-shunting of nutrient-rich blood from the DV through the foramen ovale to the left side of the
heart
increases, and left ventricular output rises in relation to the right cardiac output
-myocardium and brachiocephalic circulation has been termed redistribution, which indicates a
compensatory mechanism in response to placental insufficiency.
Late -impairment of cardiac function due to worsened SVR
-loss of diastolic forward flow in the umbilical venous circulation ….hallmark
• Finally, myocardial dysfunction and cardiac dilatation may result in holosystolic
tricuspid insufficiency and spontaneous FHR decelerations, followed by fetal demise
• Delivery should be below 34wk
 fetal organ Autoregulatory for blood flow
myocardium, adrenal glands, spleen, liver, celiac axis, mesenteric
vessels, and kidneys
• Fetal behavioral responses
 body movements and fetal breathing in the first trimester to coupling of fetal behavior (e.g.,
heart rate reactivity) and integration of rest-activity cycles into stable behavioral states (states
1F through 4F) by 28 to 32 weeks’ gestation
 BPP abnormality at 28-32 wks
DIAGNOSTIC TOOLS IN FETAL GROWTH RESTRICTI
• After confirming small fetal size, stratification into three patient groups is of particular
importance.
 Constitutionally small=not require antenatal surveillance and innervation
 Fetus with chromosomal or congenital anomaly =need family counselling
 Fetus with placental abnormality =benefit from fetal surveillance and subsequent
intervention
Fetal Biometry
• The primary measurements used to evaluate fetal growth include those of the fetal
head, AC, and long bones
• The most important calculated ultrasound variable of fetal growth is the
sonographically estimated fetal weight (SEFW
• Accurate FGR measurement need knowledge of GA
 fetal head
BPD, HC and TCD ….asymmetric FGR are not diagnosed late
…. HC is not affected by external factors unlike BPD
…. TCD relatively spared from the effects of mild to moderate uteroplacental
dysfunction
• Abdominal circumference
 The AC is the single best measurement for the detection of FGR
 higher sensitivity (98% vs. 85%) but lower positive predictive value (PPV) than the SEFW (36%
vs. 51%)
 Its sensitivity is further enhanced by serial measurements at least 14 days apart
 HC/AC ratio
 used for asymmetric FGR
 Normally HC/AC ratio > 1 before 32 wks, 1 at 32-34wks , <1 after 34 wks
 the ratio remains high in asymmetric and normal for symmetric
 Can detect 70% to 85% of FGR
 sensitivity and PPV is less than AC and SEFW
• FL/AC ratio
 Used w/n difficult measurement in HC( head position-AP, Breech ,oligohydramnios)
 The FL/AC ratio is 22 at all gestational ages from 21 weeks to term;
 therefore this ratio can be applied without knowledge of the gestational age.
 An FL/AC ratio greater than 23.5 suggests FGR.
 Sonographic estimated fetal weight (SEFW)
 calculated from a combination of directly measured parameters
 The accuracy of most formulae (±2 standard deviations [SDs]) is ± 10%,
 has a lower sensitivity but higher PPV than the AC
 most common method for characterizing fetal size and thereby growth abnormalities.
Reference Ranges That Define Fetal Growth
 Approximately 70% of infants with a birthweight below the 10th percentile are normally
grown (i.e., constitutionally small) and are not at risk for adverse outcomes
 The remaining 30% consist of infants who are truly growth restricted and are at risk for
increased perinatal morbidity and mortality
 True growth-restricted infants are identified more on 3 centile growth curve than 10 th
centile, but minimal GR fetus are missed. Advantage for prenatal surveillance
 SEFW growth curves are generated from patient samples that represent the entire
obstetric population at any gestational age. In contrast, preterm live birth normative
data tables reflect only those individuals who have delivered under abnormal
circumstances.
 range of preterm gestation than do birthweight-generated growth curves. Therefore use of
an SEFW cutoff less than the 10th percentile captures most fetuses at greater perinatal
risk
• For the AC, a cutoff of the 2.5 percentile is appropriate
 individualized growth models
 not population-based normative data and the ability to detect a true, singularly defined
growth restriction even with EFWs greater than the 10th percentile for the population.
 require three sequential sonograms( baseline biometry in the second trimester, a second
sonogram to establish growth potential, and a third scan to identify a growth abnormality
 Revised with component of early pregnancy weight, maternal height, ethnic group, parity,
and sex along with fetal growth patterns
 U/s interval for growth evaluation is Q 3wks
• Fetal Anatomic Survey
 aneuploidy, nonaneuploid syndromes, and fetal infection, as well as structural malformation
 Gives clue for symmetric IUGR and etiology of FGR
 Amniotic Fluid Assessment
 From 2nd
TMx onwards, AFV dependent on fetal urine output, production of pulmonary fluid,
and fetal swallowing
 Placental dysfunction and fetal hypoxemia both may result in decreased perfusion of the
fetal kidneys with subsequent oliguria and decreasing AFV.
 Two technique
1.SDP 2.AFI
.≥ 2cm normal
.1-2cm marginal
.<1cm decreased
 overall clinical impression of reduced amniotic fluid may be most important
In unkown GA the FL/AC ratio and a single amniotic fluid pocket is best method of
dx IUGR
 Up to 96% of fetuses with SDP <1cm may be growth restricted
 IUGR with abundant AFV suggests aneuploidy or fetal infection,
 Doppler Velocimetry
i. Arterial Doppler waveforms
 provide information on downstream vascular resistance,
 The systolic/ diastolic (S/D) ratio, the resistance index, and the pulsatility index (PI)
 increase in vascular resistance leads
 S/d ratio, PI ,RI
 or absent EDV and reversed end-diastolic velocity (REDV
ii.Venous Doppler parameters
 assessment of cardiac forward function
 triphasic flow pattern (cardiac compliance, contractility, and afterload determines forward fun
)
• The vessels that are of primary importance in the placental dysfunction are
the UA and the MCA
• combined use of fetal biometry and UA Doppler significantly reduces perinatal
mortality and iatrogenic intervention
• Vascular damage that affects approximately 30% of the placenta produces
elevations in the UA Doppler index,
• whereas more
• marked abnormalities result in AEDV or REDV. Milder forms of placental
vascular
• in fetal hypoxemia, a decrease in MCA Doppler resistance may occur
• the ratio between UA pulsatility as an index of vasoconstriction in the placenta and
MCA pulsatility as an index of vasodilation in the fetal brain
• CPR may dec in milder form of IUGR esp after 34 weeks’ gestation
• assessment of placental function should include the umbilical and MCAs
• DI >2SD shows abnormal
• Invasive Testing
 amniotic fluid R/o TORCH infection( maternal serology or PCR)
 and/or fetal blood for karyotyping or microarray analysis for chromosomal ds
SCREENING AND PREVENTION OF FETAL
• Maternal History
 prior birth of a growth-restricted infant has 25% of consecutive FGR
 After two pregnancies complicated by FGR, this risk is increased fourfold
 Maternal Serum Analytes
 Inceased HCG, HPL,ESTRIOL,MSAFP are marker of abnormal placentation &sign of FGR
 single, unexplained elevated value of 2 to 2.5 multiples of the median (MoM) raises the
risk of growth restriction 5-fold to 10-fold
 In 1st
tmx screening, a decrease in the pregnancy-associated plasma protein A (PAPP-A)
<0.8 MoM
or the placental growth factor (PlGF) has shown the most consistent predictive
performance
- PE and IUGR
Clinical Examination
 After 20 weeks’ gestation, a lag of the symphyseal-fundal height of 4 cm or
more suggests growth restriction
• sensitivities for FGR range from 27% to 85%, and the PPVs range from 18% to
50%.
• Maternal Doppler Velocimetry
 Abnormal uterine artery flow-velocity waveform 2ry to delayed trophoblast invasion
predicts gestational hypertensive disorders, FGR, and fetal demise
 In hypertensive disorders, the presence of S/D ratio >2.6 and/or diastolic notching
increased the risk for FGR and stillbirth.
 Uterine artery Doppler is better at predicting severe, rather than mild, disease
 Doppler velocimetry and maternal glucose tolerance testing results in a PPV of 94% and
a sensitivity of 54% for FGR.
 Has high NPV (0.5 forPE and 0,8 for IUGR)
Integrated Approach to Screening
• a prior history of preeclampsia, maternal first-trimester body mass index, BP,
uterine artery PI, and the PAPP-A level (MoM).
• predicting early-onset preeclampsia or FGR with 80% to 90% sensitivity and a
5% to 10% false-positive rate
Preventive Strategies
 initiation of low dose ASA at 12-16wks GA decrease PE or FGR by 50-
60%
Indications
 poor obstetric history,
 unexplained elevations in second-trimester MSAFP,
 flat oral glucose tolerance curves, and
 abnormal second-trimester uterine artery Doppler velocimetry
MANAGEMENT IN CLINICAL PRACTICE
 Elimination of contributors such as stress, smoking, and alcohol and drug use is advocated.
 bed rest in the left lateral decubitus position to increase placental blood flow.
 dietary supplementation( poor weight gain or low prepregnancy weight)
 Maternal hyperalimentation plays a role only in patients in whom malnutrition has been
established as the underlying cause of growth delay
 Maternal hyperoxygenation = 2.5l/min n. prong or 55% by facemask can extend px from 9
days to 5 wks
 However, fetal growth velocity was not improve
 fetuses subjected to oxygen therapy had more hypoglycemia,
thrombocytopenia, and DIC
Maternal volume expansion –for low volume status
ASA =FGR of 13%, compared with 61% in an untreated control group
 corticosteroids for lung maturity
 betamethasone temporarily reduces FHR variation on days 2 and 3 after the first
injection, together with a 50% decrease in fetal body movements and a near
cessation of fetal breathing movement
 Subsequently, the number of fetuses with abnormal BPP scores increases
significantly by 48 hours after steroid administration, with a return to the
preadministration state at 72 hours
 Doppler findings are not affected
 A transient decrease in the MCA blood flow resistance has been reported 48 hours after
betamethasone administration
ASSESSMENT OF FETAL WELL-BEING
 Serial ultrasound Q 3 to 4 weeks and include BPD, HC/AC ratio, fetal weight, and AFV
 The goal is to avoid stillbirth and optimize the timing of delivery
 the strongest fetal criterion for delivery are of fetal acidemia and stillbirth
• Maternal Monitoring of Fetal Activity
 the minimum requirement of 10 movements in a 2-hour period
 Fetal kick count if the above fail
• Fetal Heart Rate Analysis
NST - determined by gestational age, maturational and functional status of central
regulatory centers,
and oxygen tension
-A “reactive” NST exhibits two 15-beat accelerations above the baseline maintained for
15 seconds
in a 30-minute monitoring period
-“reactive” NST indicates absence of fetal acidemia
Nonreactive NST results, on the other hand, are often falsely positive and require further
evaluation.
repetitive decelerations may reflect fetal hypoxemia or cord compression
CST
 option for testing placental respiratory reserve and 30% of pregnancies complicated by
proven growth restriction
 prior to induction in FGR fetuses in whom induction of labor is planned, especially in
the setting of absent/reversed end-diastolic flow or oligohydramnios
Although the traditional NST is most sensitive in the prediction of fetal normoxemia,
computerized analysis appears to be superior in the prediction of hypoxemia and acidemia.
Amniotic Fluid Volume
• indirect measure of vascular status
• declining AFV is suggestive of ineffective downstream delivery of cardiac output and allows
some form of longitudinal monitoring even in the absence of Doppler studies
• amniotic fluid assessment provides the only marker of chronic hypoxemia and is the
only longitudinal monitoring component of the BPP
Biophysical Parameters
Components: fetal tone, movement, breathing movement, heart rate reactivity, and a
maximum amniotic fluid pocket
The earliest manifestations of abnormal fetal biophysical activity consist of the loss of heart
rate reactivity along with the absence of fetal breathing, Then decreased fetal tone and
movement
It assesses arterial PH in FGR without f. anomaly from 20wks
BPP <= 4 corollate PH <7.2 and if < 2, sensitivity is 100%
Normal AFI + BPP 8( NST -2) or 10 = reassuring
Doppler Ultrasound
• influenced by vascular histology, tone, and fetal Bpp
• elevated UA blood flow resistance and/or MCA brain sparing provide evidence of placental
dysfunction
• Early responses to placental insufficiency -are observed in mild placental vascular disease
when UA EDV is still present
 A decrease in the CPR provides an early and sensitive marker of redistribution of cardiac
output
 Nadir of CBF resistance reaches at 2wks aortic blood F impendance overt
growth restriction
 occur at a time when cardiac function is normal,
 preferential perfusion of vital organs and the placenta.
 Although the fetus may be hypoxemic, the risk for acidemia is low.
• Late responses to placental insufficiency -are observed when accelerating placental disease
results in loss or reversal of UA EDV, and when fetal deterioration becomes evident
 the precordial veins—including the DV, the inferior vena cava, and the umbilical
vein—are typically used in clinical practice
 development of oligohydramnios and metabolic academia is characteristic of
ineffective downstream delivery of cardiac output
 In the final stages of compromise, cardiac dilatation with holosystolic tricuspid
insufficiency, complete fetal inactivity, short-term heart rate variation less than 3.5 ms,
and spontaneous “cardiac” late decelerations of the FHR can be observed as preterminal
events
• elevation of the UA Doppler index is observed when approximately 30% of the fetal
villous vessels are abnormal.
• UA AEDV/REDV can occur when 60% to 70% of the villous vascular tree is damaged.
• Intrauterine hypoxia has been reported in 50% to 80% of fetuses with absent end-
diastolic flow
• In growth-restricted fetuses with an elevated Doppler index in the UA, brain sparing in
the presence of normal venous Doppler parameters is typically associated with
hypoxemia but a normal pH
• Abnormal venous Doppler parameters are the strongest Doppler predictors of stillbirth
Invasive Fetal Testing
• cordocentesis is rarely necessary today.
Integrated Fetal Testing and Management Protocol

More Related Content

PPTX
IUGR.pptx
PPT
Fgr report
PPTX
Iugr by dr derar ismerat
PPT
Approach to Intrauterine growth restriction
PPTX
Fetal Growth Restriction.pptx
PPTX
IUGR - intra uterine growth restriction.
PPTX
F.G.R. PANEL DISCUSSION AT FOGSI BOH CONFERENCE
PPTX
IUGR PPT.pptx
IUGR.pptx
Fgr report
Iugr by dr derar ismerat
Approach to Intrauterine growth restriction
Fetal Growth Restriction.pptx
IUGR - intra uterine growth restriction.
F.G.R. PANEL DISCUSSION AT FOGSI BOH CONFERENCE
IUGR PPT.pptx

Similar to Fetal growth restrictionor intrauterine GR (20)

PDF
Thai chậm tăng trưởng trong tử cung ACOG SMFM 2019
PPTX
Intrauterine growth restriction
PPTX
PPT
Intrauterine growth restriction
PPTX
IUGR.pptx
PPTX
Intrauterine growth restriction (IUGR).pptx
PPTX
Detection and surveillance of iugr
PPTX
Dilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptx
PPTX
INTRAUTERINE GROWTH RESTRICTION (IUGR)..
PPTX
IUGR.pptx
PPTX
Intrauterine growth retardation (IUGR)
PDF
iugr-180818145504 (1).pdf
PPTX
PPT
Intrauterine growth restriction
PPTX
FGD Tutorial 1_ Fetal growth disorders.pptx
PPT
vdocuments.mx_iugr-newedited.ppt
PPTX
INTRA UTERINE GROWTH RETARDATION
PPTX
IUGR.pptx
PDF
Trastornos del crecimiento fetal. Definición, causas y clasificación del CIR....
Thai chậm tăng trưởng trong tử cung ACOG SMFM 2019
Intrauterine growth restriction
Intrauterine growth restriction
IUGR.pptx
Intrauterine growth restriction (IUGR).pptx
Detection and surveillance of iugr
Dilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptx
INTRAUTERINE GROWTH RESTRICTION (IUGR)..
IUGR.pptx
Intrauterine growth retardation (IUGR)
iugr-180818145504 (1).pdf
Intrauterine growth restriction
FGD Tutorial 1_ Fetal growth disorders.pptx
vdocuments.mx_iugr-newedited.ppt
INTRA UTERINE GROWTH RETARDATION
IUGR.pptx
Trastornos del crecimiento fetal. Definición, causas y clasificación del CIR....
Ad

More from Robenus (14)

PPT
398743675-Normal-and-abnormal-Puerperum-PPT.ppt
PPTX
CARDIOGENIC SHOCK.pptx..for education sake
PDF
Management of Acute Obstructive Uterovaginal Anomalies _ ACOG.pdf
PPT
Resp Failure Lecture.ppt...for student's sake
PPTX
Infertility NOVAK (1).pptx..;.............
PPTX
Ectopic Pregnancy Williams26 (1).pptx...
PPTX
Pelvic Inflammatory disease by temu.pptx
PPT
pyschiatric disorder for students.It helps students to have good knowledge re...
PPTX
micro seminar.pptx
PPTX
SEMINAR ON INFLAMMATION.pptx
PPTX
The Cell cycle-Meiosis.pptx
PPTX
DNA structure section1.pptx
PPTX
Gonad seminar Presentation on.pptx
PPTX
Cell cycle-Meiosis.pptx
398743675-Normal-and-abnormal-Puerperum-PPT.ppt
CARDIOGENIC SHOCK.pptx..for education sake
Management of Acute Obstructive Uterovaginal Anomalies _ ACOG.pdf
Resp Failure Lecture.ppt...for student's sake
Infertility NOVAK (1).pptx..;.............
Ectopic Pregnancy Williams26 (1).pptx...
Pelvic Inflammatory disease by temu.pptx
pyschiatric disorder for students.It helps students to have good knowledge re...
micro seminar.pptx
SEMINAR ON INFLAMMATION.pptx
The Cell cycle-Meiosis.pptx
DNA structure section1.pptx
Gonad seminar Presentation on.pptx
Cell cycle-Meiosis.pptx
Ad

Recently uploaded (20)

PPTX
H&E Staining Procedures | Preparation, Steps, and Troubleshooting
PPTX
Role of physiotherapist in lactating mother.pptx
PPTX
X-ray_Grids.pptx how grid is effective to reduce scattered radiation?
PPTX
X-ray Reading Guide for UG MBBS students VIVA X-RAYS.pptx
PPTX
Importance of Immediate Response (1).pptx
PPTX
roleof Physiotherapy in obesity management
PPTX
ABG advance Arterial Blood Gases Analysis
PPTX
How-to-Perform-an-Internal-Audit-of-Your-Radiology-Billing-Process (1).pptx
PPTX
CBT FOR OCD TREATMENT WITHOUT MEDICATION
PPTX
Community Health Workers and gender webinar recording
PDF
Dr. Jasvant Modi - Passionate About Philanthropy
PDF
Palliative-Care-Nursing-BSc-Nursing-Sem-IV.pdf
PPT
Adrenergic drugs (sympathomimetics ).ppt
PPTX
SUPERANTIGENS.pptx evrything covered fully
PDF
dMOM_Poster_ Maternal and Newborn Health
PDF
TOP Read Articles in July 2025 - HIIJ.pdf
PPTX
Basics of pharmacology (Pharmacology I).pptx
PPTX
Microbiology is study of microorganism .
PDF
The Dr. Mykim Tran Story: A Purposeful Pursuit of Motivation & Triumph
PDF
Megan Miller Colona Illinois - Passionate About CrossFit
H&E Staining Procedures | Preparation, Steps, and Troubleshooting
Role of physiotherapist in lactating mother.pptx
X-ray_Grids.pptx how grid is effective to reduce scattered radiation?
X-ray Reading Guide for UG MBBS students VIVA X-RAYS.pptx
Importance of Immediate Response (1).pptx
roleof Physiotherapy in obesity management
ABG advance Arterial Blood Gases Analysis
How-to-Perform-an-Internal-Audit-of-Your-Radiology-Billing-Process (1).pptx
CBT FOR OCD TREATMENT WITHOUT MEDICATION
Community Health Workers and gender webinar recording
Dr. Jasvant Modi - Passionate About Philanthropy
Palliative-Care-Nursing-BSc-Nursing-Sem-IV.pdf
Adrenergic drugs (sympathomimetics ).ppt
SUPERANTIGENS.pptx evrything covered fully
dMOM_Poster_ Maternal and Newborn Health
TOP Read Articles in July 2025 - HIIJ.pdf
Basics of pharmacology (Pharmacology I).pptx
Microbiology is study of microorganism .
The Dr. Mykim Tran Story: A Purposeful Pursuit of Motivation & Triumph
Megan Miller Colona Illinois - Passionate About CrossFit

Fetal growth restrictionor intrauterine GR

  • 1. FGR
  • 2. outlines • Introduction • Etiology Fetal growth restriction • Classification • diagnosis • management • Complication • delivery timing • fetal surveillance
  • 3. Introduction • FGR is suspected when the sonographically estimated fetal weight is below the tenth percentile • Next to prematurity, intrauterine fetal growth restriction (FGR) is the second leading cause of perinatal mortality • Compared with appropriately grown counterparts, perinatal mortality rates in growth- restricted neonates are 6 to 10 times greater. Perinatal mortality rates as high as 120 per 1000 for all cases of FGR and 80 per 1000 after exclusion of anomalous infants have been reported. As many as 53% of preterm stillbirths and 26% of term stillbirths have FGR • In survivors, the incidence of intrapartum asphyxia may be as high as 50%. • Intrauterine growth restriction, fetal growth restriction (FGR), and small for gestational age (SGA) are terms frequently used interchangeably when describing the small fetus; in this chapter we use FGR.
  • 4. REGULATION OF FETAL GROWTH • Fetal growth is regulated at multiple levels and requires successful development of the placental interface between maternal and fetal compartments. • Fetal growth may be divided into three phases. Te initial phase • o hyperplasia occurs in the rst 16 weeks and is characterized   • by a rapid rise in cell number. Te second phase, which extends • up to 32 weeks’ gestation, includes both cellular hyperplasia • and hypertrophy. A ter 32 weeks, etal mass accrues by cellular hypertrophy,   • it is during this phase that most etal at and glycogen accumulate. Te corresponding etal-    growth rates during these three phases approximate 5 g/d at 15 weeks’ gestation,15 g/d at 24 weeks’, and 30 g/d at 34 weeks • Eighty percent of fetal fat gain is accrued after 28 weeks’ gestation, providing essential body stores in preparation for extrauterine life. From 32 weeks onward, fat stores increase from 3.2% of fetal body weight to 16%, which accounts for the significant reduction in body water content.3 Several possibl
  • 6. By 16 weeks’ gestation, the maternal microvillous and fetal basal layers in the placenta are only 4 μm apart, posing little resistance to passive diffusion. Elaboration of active transport mechanisms for three major nutrient classes—glucose, amino acids, and free fatty acids Later increase in villous surface and increase placental vasculature Extravillous cytotrophoblast invasion of the maternal spiral arteries results in progressive loss of the musculoelastic media, a process paralleled on the fetal side by continuous villous vascular branching. This results in significant reduction of blood flow resistance in the uterine and umbilical vessels, which converts both circulations into low- resistance, high-capacitance vascular bed Owing to these developments, as much as 600 mL/min of maternal cardiac output reaches a placental exchange area of up to 12 m2 at term. In the fetal compartment, this is matched with a blood flow volume of 200 to 300 mL/kg per minute throughout gestation. This magnitude of maternal blood flow is necessary to ensure maintenance of placental function that is energy intensive and consumes as much as 40% of the oxygen and 70% of the glucose supplied. Optimal fetal growth and development depends on a magnitude of maternal nutrient and oxygen delivery to the uterus that leaves sufficient surplus for fetal substrate utilization Of the actively transported primary nutrients, glucose is the predominant oxidative fuel, whereas amino acids are major contributors to protein synthesis and muscle bulk. Glucose and, to a lesser extent, amino acids drive the insulin-like growth factors axis and therefore stimulate longitudinal fetal growth. Near term, 18% to 25% of umbilical venous flow shunts through the DV to reach the right atrium in this high- velocity stream; 55% reaches the dominant left hepatic lobe, and 20% reaches the right liver lobe
  • 7. DEFINITION AND PATTERNS OF FETAL GROWTH RESTRICTION • classification • Based on absolute birthweight(old)  low birthweight (LBW; <2500 g),  very low birthweight (VLBW; <1500 g),  extremely low birthweight (ELBW; <1000 g), or  macrosomia (>4000 g) Based birthweight percentile (current)  very small for gestational age (VSGA; <3rd percentile),  small for gestational age (SGA; <10th percentile),  average for gestational age (AGA; 10th to 90th percentile), or  large for gestational age (LGA; >90th percentile). Draw back normal birthweight percentile, but abnormal body proportion as a result of differential growth delay may be missed Can’t d/t between the small neonate normally grown given his or her genetic potential and the neonate that is growth restricted because of a disease process.
  • 8. The ponderal index ([birthweight in grams/crown heel length]3 × 100) has a high accuracy for the identification of SGA and macrosomia. The ponderal index correlates more closely with perinatal morbidity and mortality than traditional birthweight percentiles, but it may miss the proportionally small and lean growth-restricted neonate Based on body proportion  the asymmetric growth pattern, somatic growth (e.g., the abdominal circumference [AC] and lower body) shows significant delay, whereas there is relative or absolute sparing of head growth. Two process , First, liver volume is reduced because of lack of deposition and depletion of glycogen stores as the result of limited nutrient supply, which leads to a decrease in AC. Second, elevations in placental blood flow resistance increase right cardiac afterload and promote diversion of the cardiac output toward the left ventricle because of the parallel arrangement of the fetal circulation and the presence of central shunt, This increases blood and nutrient supply to vital structures in the upper part of the body, presumably resulting in relative “head sparing  the symmetric growth pattern, body and head growth are similarly affected.
  • 9. • The pattern of fetal growth depends on the underlying cause of growth delay and on the timing and duration of the insult.  Uteroplacental insufficiency is typically associated with asymmetric fetal growth delay.  Aneuploidy, nonaneuploid (genetic) syndromes, and viral infections either disrupt the regulation of growth processes or interfere with growth at the stage of cell hyperplasia →→symmetric GR
  • 11. ETIOLOGIES OF INTRAUTERINE GROWTH RESTRICTIO  Fetal causes • Teratogenic exposure • Fetal infection 10% ≤≤ • Genetic disorders • Structural abnormalities Chromosomal abnormalities may be detected o 17% of FGR % ,,,,,, some says less than 1o% o 66% of u/s confirmed fetal malformation o 53 % of trisomy 13 and 64% trisomy 18
  • 12. Maternal cause • Hypertensive disease • Pregestational diabetes • Cyanotic cardiac disease • Autoimmune disease • Restrictive pulmonary disease • High altitude (>10,000 feet) • Tobacco/substance abuse • High altitude (>10,000 feet) • Tobacco/substance abuse • Malabsorptive ds/malnutrition • Multiple gestation • Thrombophilias • Drugs eg phenytoin
  • 13. Placental causes • Primary placental disease • Placental abruption and infarction • Placenta previa • Placental mosaicism
  • 14. MANIFESTATIONS OF FETAL GROWTH RESTRICTION Maternal Impacts o Due to poor placentation ,  suboptimal maternal volume expansion,  increased vascular reactivity, and  “flat” curve on the glucose tolerance test  Lack of spiral and radial A physiologic transformation into low-resistance vessels (expected at 22-24wks) Maternal placental floor infarcts, fetal villous obliteration, and  fibrosis
  • 15. • Fetal Impacts Metabolic manifestations Initially after oxygen and nutrient deficit ,fetal supply is compromised first, whereas placental nutrition is preferentially maintained. Both affected later on If uterine oxygen delivery falls below a critical value (0.6 mmol/kg/ min ),  Fetal hypoxemia or hypoxia  Hypoglycemia  mild hypoglycemia blunted pancreatic insulin gluconeogenesis(from liver glycogen) worsened nutrition abn worsened hypoglycemia  later on amino acids and fatty acids may procure gluconeogenesis after liver glycogen fail
  • 17. Fetal endocrine manifestations  Low glucose and amino acid low insulin and ILGF –I &II Impaired fetal GT and dec fetal linear growth  Leptin-coordinated deposition of fat stores is similarly affected.  Significant elevations of corticotropin-releasing hormone, adrenocorticotropic hormone, and cortisol and a decline in active vitamin D and osteocalcin are proportional to the severity of placental dysfunctio  These hormonal imbalances are believed to have additional negative impacts on linear and growth, bone mineralization, and the potential for postpartum catch-up growth.  Thyroid gland dysfunction may develop hypotyroidism as indicated by low levels of T3&T4 despite elevated TSH level  Elevations in serum glucagon, adrenaline, and noradrenaline …RF for adulthood DM
  • 18. • Fetal hematologic response  Polycythemia (erythropoietin release and stimulation of red blood cell (RBC) production )  Inc Oxygen carrying and the buffering capacity  elevated NRBC counts correlate with metabolic and cardiovascular status and are independent markers for poor perinatal outcome  fetal anemia and thrombocytopenia (due to placental consumption)  Fetal immune manifestation  the cellular and humoral dysfunction (WBC,IG,B-cells,t-lymphocyte…)
  • 19. • Fetal cardiovascular responses Early -adaptive in nature and result in preferential nutrient streaming to essential organs -dec umbilical venous flow volume ---earliest feature -Elevation of blood flow resistance in the pulmonary vascular bed and subdiaphragmatic circulation -shunting of nutrient-rich blood from the DV through the foramen ovale to the left side of the heart increases, and left ventricular output rises in relation to the right cardiac output -myocardium and brachiocephalic circulation has been termed redistribution, which indicates a compensatory mechanism in response to placental insufficiency. Late -impairment of cardiac function due to worsened SVR -loss of diastolic forward flow in the umbilical venous circulation ….hallmark
  • 20. • Finally, myocardial dysfunction and cardiac dilatation may result in holosystolic tricuspid insufficiency and spontaneous FHR decelerations, followed by fetal demise • Delivery should be below 34wk  fetal organ Autoregulatory for blood flow myocardium, adrenal glands, spleen, liver, celiac axis, mesenteric vessels, and kidneys
  • 21. • Fetal behavioral responses  body movements and fetal breathing in the first trimester to coupling of fetal behavior (e.g., heart rate reactivity) and integration of rest-activity cycles into stable behavioral states (states 1F through 4F) by 28 to 32 weeks’ gestation  BPP abnormality at 28-32 wks
  • 22. DIAGNOSTIC TOOLS IN FETAL GROWTH RESTRICTI • After confirming small fetal size, stratification into three patient groups is of particular importance.  Constitutionally small=not require antenatal surveillance and innervation  Fetus with chromosomal or congenital anomaly =need family counselling  Fetus with placental abnormality =benefit from fetal surveillance and subsequent intervention
  • 23. Fetal Biometry • The primary measurements used to evaluate fetal growth include those of the fetal head, AC, and long bones • The most important calculated ultrasound variable of fetal growth is the sonographically estimated fetal weight (SEFW • Accurate FGR measurement need knowledge of GA  fetal head BPD, HC and TCD ….asymmetric FGR are not diagnosed late …. HC is not affected by external factors unlike BPD …. TCD relatively spared from the effects of mild to moderate uteroplacental dysfunction
  • 24. • Abdominal circumference  The AC is the single best measurement for the detection of FGR  higher sensitivity (98% vs. 85%) but lower positive predictive value (PPV) than the SEFW (36% vs. 51%)  Its sensitivity is further enhanced by serial measurements at least 14 days apart  HC/AC ratio  used for asymmetric FGR  Normally HC/AC ratio > 1 before 32 wks, 1 at 32-34wks , <1 after 34 wks  the ratio remains high in asymmetric and normal for symmetric  Can detect 70% to 85% of FGR  sensitivity and PPV is less than AC and SEFW
  • 25. • FL/AC ratio  Used w/n difficult measurement in HC( head position-AP, Breech ,oligohydramnios)  The FL/AC ratio is 22 at all gestational ages from 21 weeks to term;  therefore this ratio can be applied without knowledge of the gestational age.  An FL/AC ratio greater than 23.5 suggests FGR.  Sonographic estimated fetal weight (SEFW)  calculated from a combination of directly measured parameters  The accuracy of most formulae (±2 standard deviations [SDs]) is ± 10%,  has a lower sensitivity but higher PPV than the AC  most common method for characterizing fetal size and thereby growth abnormalities.
  • 26. Reference Ranges That Define Fetal Growth  Approximately 70% of infants with a birthweight below the 10th percentile are normally grown (i.e., constitutionally small) and are not at risk for adverse outcomes  The remaining 30% consist of infants who are truly growth restricted and are at risk for increased perinatal morbidity and mortality  True growth-restricted infants are identified more on 3 centile growth curve than 10 th centile, but minimal GR fetus are missed. Advantage for prenatal surveillance  SEFW growth curves are generated from patient samples that represent the entire obstetric population at any gestational age. In contrast, preterm live birth normative data tables reflect only those individuals who have delivered under abnormal circumstances.  range of preterm gestation than do birthweight-generated growth curves. Therefore use of an SEFW cutoff less than the 10th percentile captures most fetuses at greater perinatal risk
  • 27. • For the AC, a cutoff of the 2.5 percentile is appropriate  individualized growth models  not population-based normative data and the ability to detect a true, singularly defined growth restriction even with EFWs greater than the 10th percentile for the population.  require three sequential sonograms( baseline biometry in the second trimester, a second sonogram to establish growth potential, and a third scan to identify a growth abnormality  Revised with component of early pregnancy weight, maternal height, ethnic group, parity, and sex along with fetal growth patterns  U/s interval for growth evaluation is Q 3wks
  • 28. • Fetal Anatomic Survey  aneuploidy, nonaneuploid syndromes, and fetal infection, as well as structural malformation  Gives clue for symmetric IUGR and etiology of FGR  Amniotic Fluid Assessment  From 2nd TMx onwards, AFV dependent on fetal urine output, production of pulmonary fluid, and fetal swallowing  Placental dysfunction and fetal hypoxemia both may result in decreased perfusion of the fetal kidneys with subsequent oliguria and decreasing AFV.  Two technique 1.SDP 2.AFI .≥ 2cm normal .1-2cm marginal .<1cm decreased  overall clinical impression of reduced amniotic fluid may be most important
  • 29. In unkown GA the FL/AC ratio and a single amniotic fluid pocket is best method of dx IUGR  Up to 96% of fetuses with SDP <1cm may be growth restricted  IUGR with abundant AFV suggests aneuploidy or fetal infection,  Doppler Velocimetry i. Arterial Doppler waveforms  provide information on downstream vascular resistance,  The systolic/ diastolic (S/D) ratio, the resistance index, and the pulsatility index (PI)  increase in vascular resistance leads  S/d ratio, PI ,RI  or absent EDV and reversed end-diastolic velocity (REDV
  • 30. ii.Venous Doppler parameters  assessment of cardiac forward function  triphasic flow pattern (cardiac compliance, contractility, and afterload determines forward fun )
  • 31. • The vessels that are of primary importance in the placental dysfunction are the UA and the MCA • combined use of fetal biometry and UA Doppler significantly reduces perinatal mortality and iatrogenic intervention • Vascular damage that affects approximately 30% of the placenta produces elevations in the UA Doppler index, • whereas more • marked abnormalities result in AEDV or REDV. Milder forms of placental vascular • in fetal hypoxemia, a decrease in MCA Doppler resistance may occur • the ratio between UA pulsatility as an index of vasoconstriction in the placenta and MCA pulsatility as an index of vasodilation in the fetal brain • CPR may dec in milder form of IUGR esp after 34 weeks’ gestation • assessment of placental function should include the umbilical and MCAs • DI >2SD shows abnormal
  • 32. • Invasive Testing  amniotic fluid R/o TORCH infection( maternal serology or PCR)  and/or fetal blood for karyotyping or microarray analysis for chromosomal ds
  • 33. SCREENING AND PREVENTION OF FETAL • Maternal History  prior birth of a growth-restricted infant has 25% of consecutive FGR  After two pregnancies complicated by FGR, this risk is increased fourfold  Maternal Serum Analytes  Inceased HCG, HPL,ESTRIOL,MSAFP are marker of abnormal placentation &sign of FGR  single, unexplained elevated value of 2 to 2.5 multiples of the median (MoM) raises the risk of growth restriction 5-fold to 10-fold  In 1st tmx screening, a decrease in the pregnancy-associated plasma protein A (PAPP-A) <0.8 MoM or the placental growth factor (PlGF) has shown the most consistent predictive performance - PE and IUGR
  • 34. Clinical Examination  After 20 weeks’ gestation, a lag of the symphyseal-fundal height of 4 cm or more suggests growth restriction • sensitivities for FGR range from 27% to 85%, and the PPVs range from 18% to 50%. • Maternal Doppler Velocimetry  Abnormal uterine artery flow-velocity waveform 2ry to delayed trophoblast invasion predicts gestational hypertensive disorders, FGR, and fetal demise  In hypertensive disorders, the presence of S/D ratio >2.6 and/or diastolic notching increased the risk for FGR and stillbirth.  Uterine artery Doppler is better at predicting severe, rather than mild, disease  Doppler velocimetry and maternal glucose tolerance testing results in a PPV of 94% and a sensitivity of 54% for FGR.  Has high NPV (0.5 forPE and 0,8 for IUGR)
  • 35. Integrated Approach to Screening • a prior history of preeclampsia, maternal first-trimester body mass index, BP, uterine artery PI, and the PAPP-A level (MoM). • predicting early-onset preeclampsia or FGR with 80% to 90% sensitivity and a 5% to 10% false-positive rate
  • 36. Preventive Strategies  initiation of low dose ASA at 12-16wks GA decrease PE or FGR by 50- 60% Indications  poor obstetric history,  unexplained elevations in second-trimester MSAFP,  flat oral glucose tolerance curves, and  abnormal second-trimester uterine artery Doppler velocimetry
  • 37. MANAGEMENT IN CLINICAL PRACTICE  Elimination of contributors such as stress, smoking, and alcohol and drug use is advocated.  bed rest in the left lateral decubitus position to increase placental blood flow.  dietary supplementation( poor weight gain or low prepregnancy weight)  Maternal hyperalimentation plays a role only in patients in whom malnutrition has been established as the underlying cause of growth delay  Maternal hyperoxygenation = 2.5l/min n. prong or 55% by facemask can extend px from 9 days to 5 wks  However, fetal growth velocity was not improve  fetuses subjected to oxygen therapy had more hypoglycemia, thrombocytopenia, and DIC
  • 38. Maternal volume expansion –for low volume status ASA =FGR of 13%, compared with 61% in an untreated control group  corticosteroids for lung maturity  betamethasone temporarily reduces FHR variation on days 2 and 3 after the first injection, together with a 50% decrease in fetal body movements and a near cessation of fetal breathing movement  Subsequently, the number of fetuses with abnormal BPP scores increases significantly by 48 hours after steroid administration, with a return to the preadministration state at 72 hours  Doppler findings are not affected  A transient decrease in the MCA blood flow resistance has been reported 48 hours after betamethasone administration
  • 39. ASSESSMENT OF FETAL WELL-BEING  Serial ultrasound Q 3 to 4 weeks and include BPD, HC/AC ratio, fetal weight, and AFV  The goal is to avoid stillbirth and optimize the timing of delivery  the strongest fetal criterion for delivery are of fetal acidemia and stillbirth • Maternal Monitoring of Fetal Activity  the minimum requirement of 10 movements in a 2-hour period  Fetal kick count if the above fail • Fetal Heart Rate Analysis NST - determined by gestational age, maturational and functional status of central regulatory centers, and oxygen tension -A “reactive” NST exhibits two 15-beat accelerations above the baseline maintained for 15 seconds in a 30-minute monitoring period -“reactive” NST indicates absence of fetal acidemia
  • 40. Nonreactive NST results, on the other hand, are often falsely positive and require further evaluation. repetitive decelerations may reflect fetal hypoxemia or cord compression CST  option for testing placental respiratory reserve and 30% of pregnancies complicated by proven growth restriction  prior to induction in FGR fetuses in whom induction of labor is planned, especially in the setting of absent/reversed end-diastolic flow or oligohydramnios Although the traditional NST is most sensitive in the prediction of fetal normoxemia, computerized analysis appears to be superior in the prediction of hypoxemia and acidemia.
  • 41. Amniotic Fluid Volume • indirect measure of vascular status • declining AFV is suggestive of ineffective downstream delivery of cardiac output and allows some form of longitudinal monitoring even in the absence of Doppler studies • amniotic fluid assessment provides the only marker of chronic hypoxemia and is the only longitudinal monitoring component of the BPP Biophysical Parameters Components: fetal tone, movement, breathing movement, heart rate reactivity, and a maximum amniotic fluid pocket The earliest manifestations of abnormal fetal biophysical activity consist of the loss of heart rate reactivity along with the absence of fetal breathing, Then decreased fetal tone and movement It assesses arterial PH in FGR without f. anomaly from 20wks BPP <= 4 corollate PH <7.2 and if < 2, sensitivity is 100% Normal AFI + BPP 8( NST -2) or 10 = reassuring
  • 42. Doppler Ultrasound • influenced by vascular histology, tone, and fetal Bpp • elevated UA blood flow resistance and/or MCA brain sparing provide evidence of placental dysfunction • Early responses to placental insufficiency -are observed in mild placental vascular disease when UA EDV is still present  A decrease in the CPR provides an early and sensitive marker of redistribution of cardiac output  Nadir of CBF resistance reaches at 2wks aortic blood F impendance overt growth restriction  occur at a time when cardiac function is normal,  preferential perfusion of vital organs and the placenta.  Although the fetus may be hypoxemic, the risk for acidemia is low.
  • 43. • Late responses to placental insufficiency -are observed when accelerating placental disease results in loss or reversal of UA EDV, and when fetal deterioration becomes evident  the precordial veins—including the DV, the inferior vena cava, and the umbilical vein—are typically used in clinical practice  development of oligohydramnios and metabolic academia is characteristic of ineffective downstream delivery of cardiac output  In the final stages of compromise, cardiac dilatation with holosystolic tricuspid insufficiency, complete fetal inactivity, short-term heart rate variation less than 3.5 ms, and spontaneous “cardiac” late decelerations of the FHR can be observed as preterminal events
  • 44. • elevation of the UA Doppler index is observed when approximately 30% of the fetal villous vessels are abnormal. • UA AEDV/REDV can occur when 60% to 70% of the villous vascular tree is damaged. • Intrauterine hypoxia has been reported in 50% to 80% of fetuses with absent end- diastolic flow • In growth-restricted fetuses with an elevated Doppler index in the UA, brain sparing in the presence of normal venous Doppler parameters is typically associated with hypoxemia but a normal pH • Abnormal venous Doppler parameters are the strongest Doppler predictors of stillbirth
  • 45. Invasive Fetal Testing • cordocentesis is rarely necessary today.
  • 46. Integrated Fetal Testing and Management Protocol

Editor's Notes

  • #4: growth is defined as an irreversible constant increase in size, and development is defined as growth in psychomotor capacity
  • #6: By 16 weeks’ gestation, the maternal microvillous and fetal basal layers in the placenta are only 4 μm apart, posing little resistance to passive diffusion. Elaboration of active transport mechanisms for three major nutrient classes—glucose, amino acids, and free fatty acids—and an increase in the villous surface area raise the capacity and efficiency of active transplacental transport. Vascular throughput across the placenta also increases in the maternal and fetal compartments. Extravillous cytotrophoblast invasion of the maternal spiral arteries results in progressive loss of the musculoelastic media, a process paralleled on the fetal side by continuous villous vascular branching. This results in significant reduction of blood flow resistance in the uterine and umbilical vessels, which converts both circulations into low-resistance, high-capacitance vascular beds. Owing to these developments, as much as 600 mL/min of maternal cardiac output reaches a placental exchange area of up to 12 m2 at term. In the fetal compartment, this is matched with a blood flow volume of 200 to 300 mL/kg per minute throughout gestation. This magnitude of maternal blood flow is necessary to ensure maintenance of placental function that is energy intensive and consumes as much as 40% of the oxygen and 70% of the glucose supplied. Optimal fetal growth and development depends on a magnitude of maternal nutrient and oxygen delivery to the uterus that leaves sufficient surplus for fetal substrate utilization. Of the actively transported primary nutrients, glucose is the predominant oxidative fuel, whereas amino acids are major contributors to protein synthesis and muscle bulk. Glucose and, to a lesser extent, amino acids drive the insulin-like growth factors axis and therefore stimulate longitudinal fetal growth. Concurrent development and maturation of the fetal circulation as a conduit for nutrient and waste delivery allows preferential partitioning of nutrients in the fetus. Nutrient- and oxygen-rich blood from the primitive villous circulation enters the fetus via the umbilical vein. The ductus venosus (DV) is the first vascular shunt encountered which modulates the proportion of umbilical venous blood that is distributed to the liver and heart. These proportions change across gestation. Near term, 18% to 25% of umbilical venous flow shunts through the DV to reach the right atrium in this high-velocity stream; 55% reaches the dominant left hepatic lobe, and 20% reaches the right liver lobes (Fig. 30.1). The direction and velocity of DV blood entering the right atrium ensures preferential streaming of nutrient-rich blood to the left ventricle, myocardium, and brain, while low-nutrient venous return is distributed to the placenta for reoxygenation and waste exchange.2 In addition to this overall distribution of left- and right-sided cardiac output, several organs can modify local blood flow to meet oxygen and nutrient demands by autoregulation. When the milestones in maternal, placental, and fetal development are met, placental and fetal growth progress normally. The metabolic and vascular maternal adaptations promote a steady and enhanced nutrient delivery to the uterus, and placental transport mechanisms allow for efficient bidirectional exchange of nutrients and waste. Placental and fetal growth across the three trimesters are characterized by sequential cellular hyperplasia, hyperplasia plus hypertrophy, and, lastly, hypertrophy alone. Placental growth follows a sigmoid curve that plateaus in midgestation preceding exponential third-trimester growth of the fetus. During this exponential fetal growth phase of 1.5% per day, initial weight gain is due to longitudinal growth and muscle bulk and therefore correlates with glucose and amino acid transport. Eighty percent of fetal fat gain is accrued after 28 weeks’ gestation, providing essential body stores in preparation for extrauterine life. From 32 weeks onward, fat stores increase from 3.2% of fetal body weight to 16%, which accounts for the significant reduction in body water content.3 Several possible mechanisms may challenge compensatory capacity of the maternal-placental-fetal unit to such an extent that failure to reach the growth potential may be the end result.
  • #7: Although birthweight percentiles are superior in identifying the small neonate, they fail to account for proportionality of growth and the growth potential of the individu
  • #8: The detection of abnormal body mass or proportions is based on anthropometric measurements and ratios that are relatively independent of sex and race and, to a certain extent, gestational age and therefore also the traditional birthweight percentiles. somatic growth (e.g., the abdominal circumference [AC] and lower body) shows significant delay, whereas there is relative or absolute sparing of head growth. Two process , First, liver volume is reduced because of lack of deposition and depletion of glycogen stores as the result of limited nutrient supply, which leads to a decrease in AC. Second, elevations in placental blood flow resistance increase right cardiac afterload and promote diversion of the cardiac output toward the left ventricle because of the parallel arrangement of the fetal circulation and the presence of central shunt, This increases blood and nutrient supply to vital structures in the upper part of the body, presumably resulting in relative “head sparing
  • #9: Specific conditions such as skeletal dysplasia may produce distinct growth patterns by their differential impacts on axial and peripheral skeletal growth. Because growth is dynamic, the pattern of growth restriction may evolve over the course of gestation. Placental disease may initially present with relative head sparing but eventually progresses to symmetric growth delay as placental insufficiency worsens. Alternatively, the acute course of a fetal viral illness may temporarily result in arrested growth with subsequent resumption of a normal growth pattern
  • #11: When the causation is intrinsic to the fetus, fetal growth restriction is symmetric (i.e., affects all organ systems equall 39). Selective fetal growth restriction (sFGR) is a specific term applied to FGR that occurs in monochorionic twins. The prognosis and risk profile can be determined based on the umbilical artery (UA) flow pattern
  • #23: An estimated date of confinement (EDC) should be based on the last menstrual period when the sonographic estimate of gestational age is within the predictive error (7 days in the first, 14 days in the second, and 21 days in the third trimester). Once the EDC is set by this method or by a first-trimester ultrasound, it should not be changed because such practice interferes with the ability to diagnose FGR.
  • #24: The most accurate AC is the smallest directly measured circumference obtained in a perpendicular plane of the upper abdomen at the level of the hepatic vein between fetal respirations. The AC percentile has both the highest sensitivity and negative predictive value for the sonographic diagnosis of FGR whether defined postnatally by birthweight percentile or ponderal index. gestation. In fetuses with asymmetric growth restriction, the HC remains larger than that of the body and results in an elevated HC/AC ratio,31 whereas the ratio remains normal in symmetric FGR, in which both direct measurements are equally affect
  • #25: (
  • #26: Approximately 70% of infants with a birthweight below the 10th percentile are normally grown (i.e., constitutionally small) and are not at risk for adverse outcomes because they present one end of the normal spectrum for neonatal size.33 The remaining 30% consist of infants who are truly growth restricted and are at risk for increased perinatal morbidity and mortalit
  • #27: For the AC, a cutoff of the 2.5 percentile is appropriate because reference ranges are based on a cross-section of small, appropriately grown preterm and term newborns. However, because reference limits are based on healthy women delivering appropriately nourished neonates at term, less than the 10th percentile cutoff is consistent with FGR. population-based normative data and the ability to detect a true, singularly defined growth restriction even with EFWs greater than the 10th percentile for the population. Some of these models require three sequential sonograms. This includes baseline biometry in the second trimester, a second sonogram to establish growth potential for an individual morphometric parameter, and a third scan to identify a growth abnormality summary, the ability to correctly identify growth-restricted fetuses at risk for adverse outcome by weight estimates alone is limited. Individualized or sequential growth assessment performs better than a single measurement of fetal size. Improved stratification of risk requires the integration of additional diagnostic tests.
  • #28: The relationship between aneuploidy and fetal anomalies such as omphalocele, diaphragmatic hernia, congenital heart defects, and sonographic markers such as echogenic bowel, nuchal thickening, and abnormal hand positioning are discussed in Chapter 9. Abnormalities of skull contour, thoracic shape, or disproportional shortening of the long bones may be suggestive of a skeletal dysplasia. Markers for viral infection may be nonspecific but include echogenicity and calcification in organs such as the brain and liver.38 Identification of any of these abnormalities on ultrasound may help to establish a differential diagnosis and can identify underlying conditions that impact the prognos
  • #29: Ultrasound criteria for a subjectively reduced AFV include a maximum vertical pocket less than 3 cm, the fetus in a flexion attitude with limited room for movement, a small or empty bladder and stomach, and molding of the uterus around the fetal body. In addition, movement of the transducer frequently generates uterine contractions, which may be associated with variable decelerations. infection, whereas normal or decreased amniotic fluid is compatible with placental insufficiency. The volume of amniotic fluid also has prognostic significance for the course of labor. Groome and colleagues42 demonstrated that oligohydramnios associated with fetal oliguria is associated with a higher rate of intrapartum complications that may be attributed to reduced placental reserve
  • #31: brain. In milder forms of placental disease with near minimal increase in UA blood flow resistance, the cerebroplacental Doppler ratio (CPR) may decrease. Grammellini and coworkers demonstrated that a value less than 1.08 identified small fetuses at risk for adverse outcome. CPR cerebrovascular ratio
  • #34: pubis. After 20 weeks’ gestation, the normal symphyseal-fundal height in centimeters approximates the weeks’ gestation after allowances for maternal height and fetal station. After 20 weeks’ gestation, a lag of the symphyseal-fundal height of 4 cm or more suggests growth restriction. The reported sensitivities of symphyseal fundal height screening for FGR range from 27% to 85%, and the PPVs range from 18% to 50%. Although the measurement of the symphyseal fundal height is a poor screening tool for the detection of FGR, the accuracy of subsequent ultrasound prediction of FGR is enhanced if clinical suspicion of FGR is based on a lagging fundal height
  • #35: Abnormal uterine artery flow-velocity waveforms are a manifestation of delayed trophoblast invasion that are highly associated with gestational hypertensive disorders, FGR, and fetal demise.50 Therefore Doppler velocimetry of the uterine arteries has been examined for its usefulness in predicting pregnancies destined to produce a growth-restricted fetus. In women with hypertensive disorders, the presence of an elevated uterine artery S/D ratio (>2.6) and/or diastolic notching increased the risk for FGR and stillbirth. The changes in uterine artery flow patterns precede those observed in the UA and antedate FGR. Subsequent studies used various cutoffs to define an abnormal test result. These include S/D ratios greater than 2.18 at 18 weeks, resistance index greater than 0.58 at 18 to 24 weeks, PI greater than the 95th percentile (1.45) at 22 to 24 weeks, or the presence of notches. The screen positive rate ranges between 5% and 13% according to the gestational age and the criterion used to define an abnormal test result. In low-risk patients, a uterine artery Doppler resistance profile that is high, persistently notched, or both identifies women at high risk for preeclampsia and FGR, with sensitivities and PPVs as high as 72% and 35%, respectively, when performed between 22 and 23 weeks’ gestation. Uterine artery Doppler is better at predicting severe, rather than mild, disease. The likelihood ratio of abnormal uterine artery impedance for the development of FGR was 3.7, with higher sensitivity for severe early-onset disease. Meta-analysis of the utility of uterine artery Doppler in the prediction of intrauterine death yields a likelihood ratio of 2.4 for patients with an abnormal result. Combining uterine artery Doppler velocimetry with other tests can improve screening sensitivity. The combination of abnormal second-trimester maternal uterine artery Doppler velocimetry and maternal glucose tolerance testing that demonstrate a “flat” response results in a PPV of 94% and a sensitivity of 54% for FGR. The presence of a normal uterine artery flow-velocity waveform bears a high negative predictive value, with a likelihood ratio of 0.5 and 0.8 for the development of preeclampsia and FGR, respectively.
  • #37: It is worth stressing that the majority of fetuses defined as growth restricted are constitutionally small and require no intervention. Approximately 15% exhibit symmetric growth restriction attributable to an early fetal insult for which there is no effective therapy. Here, an accurate diagnosis is essential. Finally, approximately 15% of small fetuses have growth restriction as a result of placental disease or reduced uteroplacental blood flow Tobacco smoke contains a number of vasoconstrictive substances. Anecdotally, the authors have observed cases of FGR with absent end-diastolic flow in the UA in which diastolic flow returned upon cessation of maternal smokin abdominal wall defects have been raised with administration in the early first trimeste
  • #38: FGR of 13%, compared with 61% in an untreated control group. No treated woman had a child with severe growth restriction (birthweight <2.3 percentile) compared with 27% in the untreated group. In 1997, a meta-analysis demonstrated a significant reduction in the frequency of FGR when low-dose aspirin (50 to 100 mg/day) was used. Higher doses (100 to 150 mg/day) were significantly more effective in preventing FGR than lower doses (50 to 80 mg/day). Based on the ASPRE trial, it appears that aspirin works best in patients with significant risk factors for FGR and that the therapeutic optimal window to commence aspirin therapy lies between 12 and 16 weeks’ gestation when branching angiogenesis of the placenta is ongoing.
  • #40: The development of repetitive decelerations may reflect fetal hypoxemia or cord compression as a result of the development of oligohydramnios and have been associated with a high perinatal mortality rate.58 cCTG, documentation of a mean minute variation less than 3.5 ms has been reported to predict a UA cord pH less than 7.20 with greater than 90% sensitivity. In addition, FHR variation usually decreases gradually in the weeks that precede the appearance of late decelerations and fetal hypoxemia and is therefore the most useful computerized FHR parameter for longitudinal assessment in FGR As with the traditional NST, gestational age, time of day, and the presence of fetal rest-activity cycles also need to be taken into account in the interpretation of computerized results
  • #41: An abnormal score of 4 or less is associated with a mean pH of less than 7.20, and sensitivity in the prediction of acidemia is 100% for a score of 2 or less. A normal score and normal AFV indicate the absence of fetal acidemia at the time of testing. Longitudinal observations in growth-restricted fetuses have shown that the BPP deteriorates late and often rapidly In summary, assessment of fetal biophysical variables provides an accurate measure of fetal status at the time of testing. In the patient with a nonreactive NST, a full five-component BPP should be performed. The development of oligohydramnios is concerning and frequently requires modification of management or delivery. The knowledge of fetal Doppler status is complementary to BPP because it improves the anticipation of fetal deterioration and provides an additional means to assess fetal state
  • #42: This utility is greatest for early-onset growth restriction, which is associated with more marked Doppler abnormalities than late-onset disease that requires delivery after 34 weeks, especially in early-onset placental dysfunction
  • #43: investigators. In the fetal compartment, elevation of the UA Doppler index is observed when approximately 30% of the fetal villous vessels are abnormal. Absence or even reversal of UA EDV can occur when 60% to 70% of the villous vascular tree is damaged.67 Intrauterine hypoxia has been reported in 50% to 80% of fetuses with absent end-diastolic flo
  • #44: In growth-restricted fetuses with an elevated Doppler index in the UA, brain sparing in the presence of normal venous Doppler parameters is typically associated with hypoxemia but a normal pH. Elevation of venous Doppler indices, either alone or in combination with umbilical venous pulsations, increases the risk for fetal acidemia. This association is strengthened by serial elevations of the DV Doppler index. Depending on the cutoff (2 vs. 3 SDs) and the combinations of veins examined, sensitivity for prediction of acidemia ranges from 70% to 90%, and specificity from 70% to 80%. Abnormal venous Doppler parameters are the strongest Doppler predictors of stillbirth. Even among fetuses with severe arterial Doppler abnormalities (e.g., AEDV or REDV), the risk of stillbirth is largely confined to those fetuses with abnormal venous Dopplers.69 The likelihood of stillbirth increases with the degree of venous Doppler abnormality. Particularly ominous venous Doppler findings are absence or reversal of the ductus venous a-wave and biphasic/triphasic umbilical venous pulsations. In the setting of a 25% stillbirth rate in a population with preterm severe FGR, these Doppler findings have a 65% sensitivity and 95% specificity
  • #45: risk. The neonatal mortality rate in fetuses with absent or reversed UA EDV ranges from 5% to 18% when the venous Doppler indices are normal. Elevation of the DV Doppler index greater than 2 SDs doubles this mortality rate, although the sensitivity is only 38% with a specificity of 98%. Delivery was indicated for maternal reasons, a BPP less than 6, oligohydramnios, documented lung maturity, or a gestational age beyond 36 weeks’ gestation. No stillbirths and no cord artery pH less than 7.20 were reported using this intensive monitoring approach